These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy. Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736 [TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation. Parajuli S; Redfield RR; Garg N; Aziz F; Mohamed M; Astor BC; Zhong W; Djamali A; Mandelbrot DA Transplantation; 2019 Jul; 103(7):1468-1476. PubMed ID: 30335696 [TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical expression of von Willebrand factor, T-cadherin, and Caveolin-1 is increased in kidney allograft biopsies with antibody-mediated injury. Teixeira AC; Távora F; de Deus E Silva MLF; Prado RMG; de Matos Esmeraldo R; de Sandes-Freitas TV Clin Exp Nephrol; 2021 Mar; 25(3):305-314. PubMed ID: 33242156 [TBL] [Abstract][Full Text] [Related]
6. The clinical and molecular significance of C4d staining patterns in renal allografts. Hayde N; Bao Y; Pullman J; Ye B; Calder BR; Chung M; Schwartz D; Alansari A; de Boccardo G; Ling M; Akalin E Transplantation; 2013 Feb; 95(4):580-8. PubMed ID: 23274969 [TBL] [Abstract][Full Text] [Related]
7. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study. Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962 [TBL] [Abstract][Full Text] [Related]
8. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure. Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900 [TBL] [Abstract][Full Text] [Related]
9. Pathology of C4d-negative antibody-mediated rejection in renal allografts. Haas M Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250 [TBL] [Abstract][Full Text] [Related]
10. The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation. Nankivell BJ; Taverniti A; Viswanathan S; Ronquillo J; Carroll R; Sharma A Am J Transplant; 2024 Jul; ():. PubMed ID: 39084463 [TBL] [Abstract][Full Text] [Related]
11. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody. Lubetzky M; Hayde N; Ó Broin P; Ajaimy M; Bao Y; Mohammed O; Schwartz D; Pullman J; Akalin E Clin Transplant; 2019 Mar; 33(3):e13469. PubMed ID: 30578675 [TBL] [Abstract][Full Text] [Related]
12. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection. Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874 [TBL] [Abstract][Full Text] [Related]
13. A case of transplant glomerulopathy early after kidney transplantation. Shimizu T; Ishida H; Tanabe T; Shirakawa H; Tanabe K; Honda K; Koike J Clin Transplant; 2011 Jul; 25 Suppl 23():34-8. PubMed ID: 21623912 [TBL] [Abstract][Full Text] [Related]